Logo image of QSI

QUANTUM-SI INC (QSI) Stock Fundamental Analysis

NASDAQ:QSI - Nasdaq - US74765K1051 - Common Stock - Currency: USD

1.74  +0.26 (+17.97%)

Premarket: 1.82 +0.08 (+4.6%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to QSI. QSI was compared to 56 industry peers in the Life Sciences Tools & Services industry. No worries on liquidiy or solvency for QSI as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, QSI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year QSI has reported negative net income.
QSI had a negative operating cash flow in the past year.
QSI had negative earnings in each of the past 5 years.
In the past 5 years QSI always reported negative operating cash flow.
QSI Yearly Net Income VS EBIT VS OCF VS FCFQSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -40.75%, QSI is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
The Return On Equity of QSI (-46.89%) is worse than 69.64% of its industry peers.
Industry RankSector Rank
ROA -40.75%
ROE -46.89%
ROIC N/A
ROA(3y)-35.58%
ROA(5y)-43.16%
ROE(3y)-39.71%
ROE(5y)-48.09%
ROIC(3y)N/A
ROIC(5y)N/A
QSI Yearly ROA, ROE, ROICQSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

QSI's Gross Margin of 52.32% is in line compared to the rest of the industry. QSI outperforms 58.93% of its industry peers.
QSI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QSI Yearly Profit, Operating, Gross MarginsQSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

7

2. Health

2.1 Basic Checks

QSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for QSI has been increased compared to 1 year ago.
There is no outstanding debt for QSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
QSI Yearly Shares OutstandingQSI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
QSI Yearly Total Debt VS Total AssetsQSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

QSI has an Altman-Z score of 2.10. This is not the best score and indicates that QSI is in the grey zone with still only limited risk for bankruptcy at the moment.
QSI has a Altman-Z score of 2.10. This is comparable to the rest of the industry: QSI outperforms 58.93% of its industry peers.
QSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.1
ROIC/WACCN/A
WACC10.76%
QSI Yearly LT Debt VS Equity VS FCFQSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 11.99 indicates that QSI has no problem at all paying its short term obligations.
QSI has a Current ratio of 11.99. This is amongst the best in the industry. QSI outperforms 96.43% of its industry peers.
QSI has a Quick Ratio of 11.76. This indicates that QSI is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of QSI (11.76) is better than 96.43% of its industry peers.
Industry RankSector Rank
Current Ratio 11.99
Quick Ratio 11.76
QSI Yearly Current Assets VS Current LiabilitesQSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for QSI have decreased by -4.62% in the last year.
The Revenue has grown by 182.62% in the past year. This is a very strong growth!
EPS 1Y (TTM)-4.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
Revenue 1Y (TTM)182.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%84.25%

3.2 Future

Based on estimates for the next years, QSI will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.65% on average per year.
Based on estimates for the next years, QSI will show a very strong growth in Revenue. The Revenue will grow by 130.80% on average per year.
EPS Next Y13.7%
EPS Next 2Y9.48%
EPS Next 3Y12.06%
EPS Next 5Y10.65%
Revenue Next Year145.87%
Revenue Next 2Y158.64%
Revenue Next 3Y162.75%
Revenue Next 5Y130.8%

3.3 Evolution

QSI Yearly Revenue VS EstimatesQSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
QSI Yearly EPS VS EstimatesQSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QSI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QSI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QSI Price Earnings VS Forward Price EarningsQSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QSI Per share dataQSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as QSI's earnings are expected to grow with 12.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.48%
EPS Next 3Y12.06%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QSI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUANTUM-SI INC

NASDAQ:QSI (5/22/2025, 8:00:01 PM)

Premarket: 1.82 +0.08 (+4.6%)

1.74

+0.26 (+17.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners29.2%
Inst Owner Change8.18%
Ins Owners4.23%
Ins Owner Change8.35%
Market Cap319.29M
Analysts77.14
Price Target3.45 (98.28%)
Short Float %16.39%
Short Ratio4.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.69%
Min EPS beat(2)-21.99%
Max EPS beat(2)8.61%
EPS beat(4)3
Avg EPS beat(4)8.48%
Min EPS beat(4)-21.99%
Max EPS beat(4)30.69%
EPS beat(8)7
Avg EPS beat(8)9.95%
EPS beat(12)9
Avg EPS beat(12)2.44%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.8%
Min Revenue beat(2)-27.8%
Max Revenue beat(2)-3.79%
Revenue beat(4)1
Avg Revenue beat(4)-8.72%
Min Revenue beat(4)-27.8%
Max Revenue beat(4)6.09%
Revenue beat(8)2
Avg Revenue beat(8)-21.73%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.54%
EPS NY rev (1m)0%
EPS NY rev (3m)15.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-24.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 104.41
P/FCF N/A
P/OCF N/A
P/B 1.48
P/tB 1.48
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS0.02
BVpS1.17
TBVpS1.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.75%
ROE -46.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.32%
FCFM N/A
ROA(3y)-35.58%
ROA(5y)-43.16%
ROE(3y)-39.71%
ROE(5y)-48.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 100.91%
Cap/Sales 151.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.99
Quick Ratio 11.76
Altman-Z 2.1
F-Score4
WACC10.76%
ROIC/WACCN/A
Cap/Depr(3y)214.69%
Cap/Depr(5y)249.92%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
EPS Next Y13.7%
EPS Next 2Y9.48%
EPS Next 3Y12.06%
EPS Next 5Y10.65%
Revenue 1Y (TTM)182.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%84.25%
Revenue Next Year145.87%
Revenue Next 2Y158.64%
Revenue Next 3Y162.75%
Revenue Next 5Y130.8%
EBIT growth 1Y0.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year10.28%
EBIT Next 3Y5.81%
EBIT Next 5Y9.27%
FCF growth 1Y6.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.64%
OCF growth 3YN/A
OCF growth 5YN/A